Article
Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.
The Journal of clinical investigation - 1 Oct 2013
Ho Jennifer E, Chen Wei-Yu, Chen Ming-Huei, Larson Martin G, McCabe Elizabeth L, Cheng Susan, Ghorbani Anahita, Coglianese Erin, Emilsson Valur, Johnson Andrew D, Walter Stefan, Franceschini Nora, O'Donnell Christopher J, Dehghan Abbas, Lu Chen, Levy Daniel, Newton-Cheh Christopher, Lin Honghuang, Felix Janine F, Schreiter Eric R, Vasan Ramachandran S, Januzzi James L, Lee Richard T, Wang Thomas J
Abstract excerpt
The suppression of tumorigenicity 2/IL-33 (ST2/IL-33) pathway has been implicated in several immune and inflammatory diseases. ST2 is produced as 2 isoforms. The membrane-bound isoform (ST2L) induces an immune response when bound to its ligand, IL-33. The other isoform is a soluble protein (sST2) that is thought to be a decoy receptor for IL-33 signaling. Elevated sST2 levels in serum are associated with an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
